DecisionPoint Financial’s TG Therapeutics TGTX Stock Holding History

DecisionPoint Financial’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$54	Buy	+1	New	+$54	﹤0.01%	1348

Other funds holding TGTX

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

DecisionPoint Financial's TGTX Position: Q3 2026 in Review

DecisionPoint Financial opened a new position in TG Therapeutics (TGTX) in Q3 2026: 1 share worth $54. The stake represents ﹤0.01% of the portfolio and ranks #1348 among its holdings.

110 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

DecisionPoint Financial held 1 share of TG Therapeutics worth $54 as of Q3 2026.
TG Therapeutics was a new DecisionPoint Financial position in Q3 2026.
TG Therapeutics made up ﹤0.01% of DecisionPoint Financial's portfolio in Q3 2026, its #1348 holding.
110 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.